Medicine
Regonol 10 mg/2 mL injection
Regonol 10 mg/2 mL injection is a prescription medicine containing Pyridostigmine for intravenous, parenteral use, marketed by Sandoz, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°-30°C (59°-86°F). Protect…
Key facts
- Active ingredient (INN)
- Pyridostigmine
- Brand
- Regonol
- Strength
- 10 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous, parenteral
- Packs
- 10 ampules of 2 mL
- Marketing authorisation holder
- Sandoz
- Manufacturer
- Sandoz
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°-30°C (59°-86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07AA02 Pyridostigmine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 May 2005
- Identifiers
- RxCUI 903851, 903855DailyMed set ID 208af931-a44e-43bf-a265-8e08534dc55fNDC 0781-3040Application NDA017398
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 ampule in 1 carton / 2 mL in 1 ampule | 0781-3040-95 | Sandoz | 10 May 2005 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 April 1955 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Pyridostigmine
Clinical summary
Pyridostigmine is a cholinesterase inhibitor. It is available as tablets, oral solution and extended-release tablets for intravenous and parenteral use. MedsAcross supplies Pyridostigmine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PyridostigmineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mestinon prescribing information (Bausch Health) · U.S. National Library of Medicine, DailyMed
Need Regonol 10 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.